Clayton, Dubilier & Rice (“CD&R”) and Healogics Holding Corp. have completed the previously-announced acquisition of Healogics, a provider of advanced wound care services, from Metalmark Capital and Scale Venture Partners. The transaction is valued at approximately $910 million.
Healogics operates nearly 600 hospital outpatient Wound Care Centers, or roughly one-third of all hospital outpatient wound care centers in the US, and treated over 215,000 patients in 2013. In addition, the company operates Sechrist Industries, a global manufacturer of hyperbaric oxygen therapy chambers used in advanced wound care. Healogics had approximately $300 million in sales in 2013. The company has more than 2,000 employees and is headquartered in Jacksonville, FL (www.healogics.com).
Clayton, Dubilier & Rice focuses on producing financial returns through building stronger more profitable businesses. Since inception, the firm has managed the investment of more than $19 billion in 59 businesses representing a range of industries with an aggregate transaction value of approximately $90 billion. Founded in 1978, Clayton, Dubilier & Rice is based in New York and London (www.cdr-inc.com).
“CD&R is a proven builder of businesses and we are pleased to welcome the firm as our new partner,” said Healogics President and CEO Jeff Nelson. “We thank the Metalmark team for its help in making us a premier provider of wound care services with the scale and services required to meet the critical needs of patients suffering from debilitating and chronic wounds across the healthcare continuum. We look forward to this next chapter in our history.”
Metalmark Capital was established by the principals of Morgan Stanley Capital Partners (MSCP) to manage the Metalmark Capital and MSCP funds. Since 1986, the Metalmark Capital and MSCP funds have invested $7 billion of equity capital in over 100 companies. These companies span a range of industries, including energy and natural resources, industrials and healthcare. Metalmark Capital is currently investing through its latest fund that has $2.5 billion of committed capital. The firm is based in New York (www.metalmarkcapital.com).
“CD&R is a proven builder of businesses and we are pleased to welcome the firm as our new partner,” said Mr. Nelson. “We thank the Metalmark team for its help in making us a premier provider of wound care services with the scale and services required to meet the critical needs of patients suffering from debilitating and chronic wounds across the healthcare continuum. We look forward to this next chapter in our history.”
2014 PEPD • Private Equity’s Leading News Magazine • 7-2-14
